Bioventus (BVS) Deferred Taxes (2020 - 2026)
Bioventus' (BVS) quarterly Deferred Taxes came in at $135000.0 in Q1 2026, up 213.95% YoY from $43000.0 in Q1 2025, and up 111.94% on a QoQ basis from -$1.1 million in Q4 2025.
Bioventus (BVS) Deferred Taxes (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Deferred Taxes data on file, last reported at $135000.0 in Q1 2026.
- Quarterly Deferred Taxes rose 213.95% year-over-year to $135000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$817000.0 (up 84.96% YoY) and the FY2025 annual result came in at -$909000.0, up 83.15% from the prior year.
- Deferred Taxes advanced to $135000.0 in Q1 2026, from -$1.1 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $3.2 million in Q4 2024 to a low of -$17.0 million in Q2 2022.
- A 5-year average of -$3.5 million and a median of -$693500.0 in 2023 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2022 — Deferred Taxes plunged 20603.61% — and 2026, when it soared 213.95%.
- Tracing BVS's Deferred Taxes over 5 years: stood at -$11.8 million in 2022, then jumped by 109.88% to $1.2 million in 2023, then soared by 176.44% to $3.2 million in 2024, then tumbled by 135.18% to -$1.1 million in 2025, then jumped by 111.94% to $135000.0 in 2026.
- The last three Deferred Taxes figures came in at $135000.0 (Q1 2026), -$1.1 million (Q4 2025), and $135000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 600,000.00 |
| 10 | Bioventus | 972.56 Mn | 943.11 Mn | 105.67 Mn | -22.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -22.29 Mn |
| Mar 28, 2026 | 135,000.00 |
| Dec 31, 2025 | -1.13 Mn |
| Sep 27, 2025 | 135,000.00 |
| Jun 28, 2025 | 44,000.00 |
| Mar 29, 2025 | 43,000.00 |
| Dec 31, 2024 | 3.22 Mn |
| Sep 28, 2024 | -511,000.00 |
| Jun 29, 2024 | -8.18 Mn |
| Mar 30, 2024 | 81,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Jul 1, 2023 | -876,000.00 |
| Apr 1, 2023 | -2.66 Mn |
| Dec 31, 2022 | -11.77 Mn |
| Oct 1, 2022 | -7.19 Mn |
| Jul 2, 2022 | -10.68 Mn |
| Apr 2, 2022 | -17.02 Mn |
| Dec 31, 2021 | -8.05 Mn |
| Oct 2, 2021 | -722,000.00 |
| Jul 3, 2021 | -1.06 Mn |